Aldeyra Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Aldeyra Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 9, 2026, to elect directors, ratify auditor appointments, and vote on executive compensation.
NASDAQ
DEFA14A: Aldeyra Therapeutics Sets Date for 2025 Annual Meeting, Outlines Proposals for Stockholder Vote
Aldeyra Therapeutics has scheduled its 2025 Annual Meeting for June 10, 2025, and is seeking stockholder votes on key proposals including the election of directors and ratification of the company's accounting firm.
NASDAQ
Aldeyra Therapeutics announces its 2025 Annual Meeting of Stockholders to be held on June 10, 2025, featuring proposals for director elections, auditor ratification, and executive compensation advisory vote.
NASDAQ
DEFA14A: Aldeyra Therapeutics Sets Date for 2024 Annual Meeting, Outlines Proposals for Stockholder Vote
Aldeyra Therapeutics has scheduled its annual stockholder meeting for June 4, 2024, and is seeking votes on the election of directors, ratification of the company's accounting firm, and executive compensation.
NASDAQ
Aldeyra Therapeutics announces its 2024 Annual Meeting of Stockholders to be held on June 4, 2024, covering director elections, auditor ratification, and executive compensation.